Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Investor Inquiries

Kate Rausch
Investor Relations
617-949-4827
krausch@wavelifesci.com
Information request >

Email Alerts

Sign up here to receive email alerts from Wave Life Sciences.

Press Releases

Press Releases

Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery

Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update

Wave Life Sciences to Webcast Conference Call of First Quarter 2020 Financial Results on May 11, 2020

Wave Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference

Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntington’s Disease Program at CHDI Foundation’s 15th Annual HD Therapeutics Conference

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020